Skip to main content
. Author manuscript; available in PMC: 2015 Jul 2.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Apr 6;21(6):895–904. doi: 10.1158/1055-9965.EPI-12-0192

Table 2.

Multivariate-adjusted percentages of respondents ages 50 to 75 years who reported CRC tests within recommended time intervals, by sociodemographic and health care access variables, National Health Interview Survey (NHIS), 2010

Characteristic Home FOBT within past year
Sigmoidoscopy within past 5 y with FOBT within past 3 y
Colonoscopy within past 10 y
Any CRC test within recommended time interval
%a (95% CI) Pb %a (95% CI) Pb %a (95% CI) Pb %a (95% CI) Pb
Gender 0.79 0.20 0.80 0.82
 Male 8.9 (8.0–10.0) 1.5 (1.1–2.0) 54.5 (52.6–56.4) 58.3 (56.5–60.1)
 Female 8.7 (7.8–9.7) 1.1 (0.8–1.5) 54.8 (53.2–56.5) 58.6 (56.9–60.2)
Race 0.84 0.58 <0.0001 <0.0001
 White 8.9 (8.1–9.7) 1.3 (1.0–1.6) 55.0 (53.6–56.4) 58.9 (57.5–60.3)
 Black 8.6 (6.8–10.7) 1.6 (1.1–2.6) 57.5 (54.6–60.4) 60.6 (57.6–63.5)
 Asian 7.5 (5.0–10.9) 1.3 (0.5–3.1) 41.3 (36.5–46.2) 44.3 (39.2–49.4)
 American Indian/Alaska nativec 8.8 (4.1–17.9) 48.8 (35.7–62.1) 51.7 (38.6–64.5)
Hispanic or Latino 0.12 0.32 0.46 0.20
 No 8.9 (8.2–9.7) 1.3 (1.1–1.7) 54.8 (53.4–56.2) 58.7 (57.3–60.0)
 Yes 7.1 (5.4–9.3) 0.8 (0.3–2.1) 53.4 (49.9–57.0) 56.4 (52.9–59.8)
Age, y 0.06 0.13 <0.0001 <0.0001
 50–59 7.6 (6.4–8.9) 0.9 (0.6–1.4) 48.0 (45.8–50.2) 52.0 (49.9–54.1)
 60–69 9.9 (8.8–11.1) 1.5 (1.1–2.1) 60.3 (58.4–62.2) 64.0 (62.1–65.9)
 70–75 10.0 (7.9–12.5) 2.0 (1.0–3.8) 62.9 (59.0–66.6) 66.2 (62.3–69.8)
Education <0.0001 0.023 <0.0001 <0.0001
 <12 y 6.1 (4.7–7.8) 1.1 (0.7–1.7) 47.6 (44.4–50.9) 50.8 (47.5–54.2)
 High school graduate 6.8 (5.8–8.1) 0.8 (0.5–1.5) 51.9 (49.5–54.3) 54.7 (52.3–57.0)
 Some college 10.5 (9.1–12.0) 1.1 (0.7–1.6) 56.6 (54.4–58.7) 61.0 (58.8–63.1)
 College graduate 10.3 (9.0–11.8) 1.9 (1.5–2.6) 58.7 (56.3–61.1) 63.1 (60.8–65.3)
Annual family income 0.45 0.69 <0.0001 <0.0001
 <$35,000 9.7 (8.3–11.2) 1.1 (0.7–1.7) 49.1 (46.8–51.4) 54.1 (51.8–56.4)
 $35,000–49,999 7.9 (6.3–9.9) 1.1 (0.6–2.0) 52.7 (49.6–55.9) 56.0 (52.9–59.0)
 $50,000–74,999 8.4 (6.9–10.2) 1.3 (0.8–2.2) 55.4 (52.6–58.2) 58.0 (55.2–60.8)
 $75,000–99,999 9.6 (7.6–12.0) 1.9 (1.1–3.4) 56.2 (52.6–59.7) 61.0 (57.5–64.5)
 ≥$100,000 8.3 (6.9–9.9) 1.3 (0.7–2.2) 61.6 (58.6–64.5) 64.5 (61.5–67.4)
Health care insurance 0.0001 0.43 <0.0001 <0.0001
 Private (50–64) 8.3 (7.2–9.4) 1.3 (0.9–1.8) 56.9 (54.9–58.8) 60.3 (58.4–62.2)
 Private (65–75) 9.8 (7.8–12.2) 1.3 (0.7–2.1) 60.8 (57.1–64.3) 64.7 (61.0–68.1)
 Medicare without private (65–75) 9.4 (7.3–12.0) 1.6 (0.9–2.9) 54.0 (49.9–57.9) 58.1 (54.1–61.9)
 Military without private (50–64) 17.5 (12.4–24.2) 2.3 (1.1–4.8) 64.0 (57.5–70.0) 74.5 (68.3–79.9)
 Only government/public (other than above) 9.6 (7.2–12.8) 1.0 (0.4–2.3) 50.4 (45.7–55.1) 54.2 (49.5–58.8)
 None/single service 4.3 (2.7–6.7) 0.4 (0.0–2.9) 31.4 (27.4–35.6) 34.4 (30.3–38.7)
Usual source of health care 0.0001 0.31 <0.0001 <0.0001
 No 3.1 (1.8–5.3) 0.5 (0.1–3.4) 29.7 (25.2–34.6) 32.4 (27.7–37.3)
 Yes 9.2 (8.5–10.0) 1.3 (1.1–1.7) 56.7 (55.3–58.0) 60.6 (59.2–61.8)
a

Adjusted percentages presented as predictive margins from multivariate logistic regression models (adjusted for all other characteristics in Table 2).

b

P values are based on an overall Wald F test for association from multivariate logistic regression models.

c

American Indians/Alaska natives could not be included in the sigmoidoscopy model due to insufficient numbers.